PAVmed Inc (NASDAQ: PAVM) on Monday, soared 16.03% from the previous trading day, before settling in for the closing price of $0.62. Within the past 52 weeks, PAVM’s price has moved between $0.57 and $3.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 131.45%. The company achieved an average annual earnings per share of 127.29%. With a float of $9.73 million, this company’s outstanding shares have now reached $10.66 million.
Let’s determine the extent of company efficiency that accounts for 107 employees. In terms of profitability, gross margin is -98.76%, operating margin of -1380.29%, and the pretax margin is 244.84%.
PAVmed Inc (PAVM) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of PAVmed Inc is 12.12%, while institutional ownership is 13.66%. The most recent insider transaction that took place on Dec 12 ’24, was worth 7,380. Before that another transaction happened on Dec 09 ’24, when Company’s Director proposed sale 38,095 for $0.86, making the entire transaction worth $32,739.
PAVmed Inc (PAVM) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 127.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 59.25% during the next five years compared to 6.21% growth over the previous five years of trading.
PAVmed Inc (NASDAQ: PAVM) Trading Performance Indicators
PAVmed Inc (PAVM) is currently performing well based on its current performance indicators. A quick ratio of 0.05 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.31, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -1.16 in one year’s time.
Technical Analysis of PAVmed Inc (PAVM)
Looking closely at PAVmed Inc (NASDAQ: PAVM), its last 5-days average volume was 0.17 million, which is a drop from its year-to-date volume of 0.2 million. As of the previous 9 days, the stock’s Stochastic %D was 38.15%. Additionally, its Average True Range was 0.06.
During the past 100 days, PAVmed Inc’s (PAVM) raw stochastic average was set at 12.31%, which indicates a significant decrease from 82.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.65% in the past 14 days, which was lower than the 87.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7181, while its 200-day Moving Average is $1.0767. However, in the short run, PAVmed Inc’s stock first resistance to watch stands at $0.7729. Second resistance stands at $0.8265. The third major resistance level sits at $0.9029. If the price goes on to break the first support level at $0.6429, it is likely to go to the next support level at $0.5665. Should the price break the second support level, the third support level stands at $0.5129.
PAVmed Inc (NASDAQ: PAVM) Key Stats
Market capitalization of the company is 7.96 million based on 11,069K outstanding shares. Right now, sales total 2,450 K and income totals -64,180 K. The company made 1,000 K in profit during its latest quarter, and 64,400 K in sales during its previous quarter.
